[PRESS RELEASE] – AUSTIN, Texas & EINDHOVEN, Netherlands, June 18, 2025 – Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis production, announced SPYDR 3, the latest generation of the cannabis industry’s pioneering fixture.

SPYDR 3 features the line’s signature design, now with five wattage options that provide exceptional flexibility to growers. With output up to 2,260 μmol/s, efficiency up to 3.0 μmol/J and new spectrum options—including Fluence’s BW4a, BW45 and BW5—SPYDR 3 optimizes energy savings while enabling growers to hit desired light levels.

“Ten years ago, Fluence introduced a transformative luminaire to the cannabis industry that revolutionized indoor cultivation,” said Michiel van Dam, president of Agricultural Lighting at Signify. “Today, SPYDR is the technology of choice for growers seeking maximum yield and quality at the greatest efficiencies in their facilities. With enhanced wattage options, additional research-backed spectra, and versatile sizing, we’re not just meeting growers’ needs—we’re delivering them the lighting technology they need to dominate in their markets.”

The third-generation SPYDR also features an integrated power supply and sealed lens design, providing a cleanable barrier lens to protect it from the cultivation environment. The fixture’s high-light intensity options and substantial efficiencies also support growers seeking rebate incentives.

Learn more about SPYDR 3 or contact the Fluence team about implementing SPYDR at your facility here. For more information on Fluence, visit www.fluence-led.com.

Maine’s cPort Credit Union is canceling its medical cannabis caregiver storefront accounts due to a lack of state regulations, WMTW reports.

In Maine, caregiver storefronts can legally sell cannabis products to patients, but they are smaller businesses than dispensaries and do not operate within the same licensing structure.

Andrew Pettingill, the owner of Portland-based Evergreen Cannabis Company, told the news station that he received via email a letter from the credit union’s president and CEO, Kelsey Marquis, saying that his business account — and all other unaffiliated caregiver accounts held with the credit union — will be closed on July 31.

“cPort Credit Union has made the difficult decision to discontinue financial services for caregiver accounts that are not affiliated with a licensed cannabis dispensary or adult-use cannabis business. As banking regulatory expectations continue to evolve, we have carefully reassessed our risk exposure and concluded that this change is necessary to ensure ongoing compliance with federal and state expectations.” — Marquis, email excerpt via WMTW

Meanwhile, the Maine Office of Cannabis Policy (OCP) has proposed bills to align the banking regulations for medical cannabis caregivers with those for cannabis license-holders, but lawmakers have repeatedly rejected the proposals, the report said.

“Now they’re saying, OK, we’ll go back to no banks, just put your money in shoeboxes,” Pettingale said in the report.

Get daily cannabis business news updates. Subscribe

Ganjapreneur is made possible by our partners:

“I look forward to having a conversation with the Governor to learn more about her concerns regarding the bill.”

By Cami Koons, Iowa Capital Dispatch

A key lawmaker said he was surprised by Gov. Kim Reynolds’s (R) veto last week of a bill that would have allowed for the prescription and distribution of synthetic psilocybin, the psychoactive compound in “magic mushrooms” following federal approval of the drug.

Reynolds said the bill “moves ahead” of public health systems, law enforcement and regulatory systems in the state.

“This decision is not a dismissal of the emerging science or the sincere advocacy behind this legislation,” Reynolds said in her explanation of the veto. “Rather, it is a call for a more deliberate and Iowa-centric approach.”

House File 383 was one of two bills from the Iowa House this year that sought to legalize the use of psychedelics as a treatment for mental health issues, like post-traumatic stress disorder.

The bill’s floor manager, Rep. Brett Barker (R-Nevada) said the veto from the governor was “unexpected” considering the bill passed with unanimous consent in both chambers.

“I look forward to having a conversation with the Governor to learn more about her concerns regarding the bill,” Barker said in an email.

The other bill, House File 978, would have created a psilocybin licensing board in Iowa, and similar to the state’s medical marijuana program, would have allowed eligible patients access to the drug while it is still federally classified as Schedule I substance.

The bill advanced from the House but was not heard in the Senate.

HF 383, the bill put before the governor, would have immediately rescheduled any drugs containing crystalline polymorph psilocybin, the synthetic version of the compound, if they were approved for use by the U.S. Food and Drug Administration (FDA).

Under the bill and conditioned circumstances, it would be legal to prescribe, distribute and market drugs with the ingredient, which is also sometimes referred to as COMP360.

Clinical trials of COMP360 as a treatment for PTSD and treatment resistant depression have been conducted and are ongoing.

A similar bill was signed into law in Colorado in March. Colorado and Oregon are the only states with legalized medical licensing programs for psilocybin.

Reynolds said she does “recognize and respect the growing body of research into the potential therapeutic benefits of psilocybin” but she said the compound should be approved by FDA and the Drug Enforcement Agency before Iowa acts to reschedule.

“The pathway provided by this bill for legalization of psilocybin at the state level before we have a chance to review federal action…creates legal uncertainty, poses risks for misuse and could undermine broader efforts to ensure safe and effective therapeutic use in the future,” Reynolds said.

This story was first published by Iowa Capital Dispatch.

Psychedelic Therapy Can Help Reduce Problematic Alcohol And Tobacco Use, Scientific Review Shows